Filtros de búsqueda

Lista de obras de

A Canadian context for the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) trial

artículo científico publicado en 2008

A National Survey of Mentoring Practices for Young Investigators in Circulatory and Respiratory Health

artículo científico publicado en 2016

A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

artículo científico publicado en 2009

A comparison of the effects of selective and non-selective mineralocorticoid antagonism on glucose homeostasis of heart failure patients with glucose intolerance or type II diabetes: A randomized controlled double-blind trial

artículo científico publicado en 2018

A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin

artículo científico publicado en 2005

A disease-specific comorbidity index for predicting mortality in patients admitted to hospital with a cardiac condition

artículo científico publicado en 2019

A forme fruste of Shone's anomaly in a 65 year-old patient.

artículo científico publicado en 2008

A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy

scientific article published on 01 September 2020

A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry

scientific article published on 06 June 2020

A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure.

artículo científico publicado en 2018

A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure

artículo científico publicado en 2015

A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design

artículo científico publicado en 2007

A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors

artículo científico publicado en 2005

AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post‐MI ⬇️

artículo científico publicado el 1 de abril de 2003

Activation of vascular tissue angiotensin-converting enzyme (ACE) in heart failure. Effects of ACE inhibitors

artículo científico publicado en 2002

Acute Pulmonary Edema and Acute Coronary Syndrome: Mostly a Trigger or an Associated Phenomenon?

artículo científico publicado en 2015

Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome

scientific article published on 09 October 2009

Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON) ⬇️

artículo científico publicado el 1 de octubre de 2003

Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction

artículo científico publicado en 2004

An approach to the rational use of revascularization in heart failure patients

artículo científico publicado en 2013

An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry

artículo científico publicado en 2004

Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling

artículo científico publicado en 2004

Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial

artículo científico publicado en 2017

Angiotensin receptor blockers vs. angiotensin converting enzyme inhibitors and acute coronary syndrome outcomes in elderly patients: a population-based cohort study (UMPIRE study results).

artículo científico publicado en 2007

Angiotensin receptor blockers: powerful evidence with cardiovascular outcomes?

artículo científico publicado en 2002

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure

artículo científico publicado en 2014

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

scientific article published on 01 September 2019

Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the

artículo científico publicado en 2006

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

artículo científico publicado en 2004

Angiotensin-neprilysin inhibition versus enalapril in heart failure

artículo científico publicado en 2014

Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial

artículo científico publicado en 2004

Aortic regurgitation in patients with a left ventricular assist device: A contemporary review

scientific article published on 07 September 2018

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

artículo científico publicado en 2022

Application of the H2 FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial

scientific article published on 22 July 2019

Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study

artículo científico publicado en 2006

Assessing Splanchnic Compartment Using Portal Venous Doppler and Impact of Adding It to the EVEREST Score for Risk Assessment in Heart Failure

artículo científico publicado en 2020

Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial

scientific article published on 01 October 2018

Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial

scientific article published on 11 July 2018

Atrial fibrillation in heart failure: drug therapies for rate and rhythm control.

artículo científico

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial

artículo científico publicado en 2019

Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial

artículo científico publicado en 2018

Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).

artículo científico publicado en 2014

Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat.

artículo científico publicado en 2002

Bradykinin metabolism in rat hearts with left-ventricular hypertrophy following myocardial infarction

artículo científico publicado en 2003

Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy

scientific article published on 30 January 2019

CSCI/RCPSC HENRY FRIESEN LECTURE: Clinical research in Canada: the dawn of a new era?

artículo científico

Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction

scientific article published on 01 November 2018

Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial

artículo científico publicado en 2014

Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both

Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.

artículo científico publicado en 2005

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure ⬇️

artículo científico publicado el 14 de noviembre de 2010

Cardioprotective effects of vasopeptidase inhibitors

artículo científico publicado en 2002

Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network

artículo científico publicado en 2012

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

artículo científico publicado en 2003

Care Gaps in Adherence to Heart Failure Guidelines: Clinical Inertia or Physiological Limitations?

scientific article published on 07 August 2020

Challenges to Data Monitoring Committees When Regulatory Authorities Intervene

artículo científico publicado en 2016

Changes in cardiopulmonary reserve and peripheral arterial function concomitantly with subclinical inflammation and oxidative stress in patients with heart failure with preserved ejection fraction

artículo científico publicado en 2014

Characterization of myocardium, isolated cardiomyocytes, and blood pressure in WKHA and WKY rats

artículo científico publicado en 2002

Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.

artículo científico publicado en 2004

Circulating biomarkers in patients with heart failure and preserved ejection fraction

artículo científico publicado en 2013

Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial.

artículo científico publicado en 2015

Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy

artículo científico publicado en 2004

Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure

artículo científico publicado en 2003

Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure

artículo científico publicado en 2003

Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF.

artículo científico publicado en 2015

Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction

artículo científico publicado en 2020

Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)

scientific article published on 24 November 2018

Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research

artículo científico publicado en 2005

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

artículo científico publicado en 2002

Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus

artículo científico publicado en 2008

Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat

scientific article published on 01 May 2002

Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure

artículo científico publicado en 2002

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy

artículo científico publicado en 2017

Coronary Arteriography Should Not Be Routinely Used Postinfarction in Patients Having Received Thrombolytic Therapy

scientific article published on 01 February 1995

Coronary bypass surgery with or without surgical ventricular reconstruction

artículo científico publicado en 2009

Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy

scientific article published on 03 April 2016

Coronary-artery bypass surgery in patients with left ventricular dysfunction

artículo científico publicado en 2011

Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction

artículo científico publicado en 2016

Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction

artículo científico publicado en 2016

Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction

artículo científico publicado en 2011

Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States

artículo científico publicado en 2013

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women

scientific article published on 01 January 2019

Diuretic Strategies in Patients with Acute Decompensated Heart Failure ⬇️

artículo científico publicado el 3 de marzo de 2011

Do statins prevent heart failure in patients after myocardial infarction?

artículo científico publicado en 2004

Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial

artículo científico publicado en 2019

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine I

article

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

artículo científico publicado en 2004

Editorial independence for CMAJ: signposts along the road

artículo científico publicado en 2006

Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF

artículo científico publicado en 2020

Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2).

artículo científico publicado en 2013

Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction

artículo científico publicado en 2007

Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)

scientific article published on 01 July 2004

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

artículo científico publicado en 2002

Effect of chronic treatment with bovine recombinant growth hormone on cardiac dysfunction and lesion progression in UM-X7.1 cardiomyopathic hamsters

artículo científico publicado en 2002

Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial

artículo científico publicado en 2018

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial

scientific article published on March 2013

Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

artículo científico publicado en 2018

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.

artículo científico publicado en 2017

Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients

artículo científico publicado en 2015

Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction

article

Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy

artículo científico

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF

scientific article published on 01 February 2019

Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction

artículo científico publicado en 2020

Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial

artículo científico publicado en 2018

Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery

artículo científico publicado en 2007

Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial

artículo científico publicado en 2003

Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expression

artículo científico publicado en 2002

Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).

artículo científico publicado en 2003

Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure

artículo científico publicado en 2007

Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker

artículo científico publicado en 2009

Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study

artículo científico publicado en 2003

Effects of pre-, peri-, and postmyocardial infarction treatment with losartan in rats: effect of dose on survival, ventricular arrhythmias, function, and remodeling

artículo científico publicado en 2004

Effects of pre-, peri-, and postmyocardial infarction treatment with omapatrilat in rats: survival, arrhythmias, ventricular function, and remodeling

scientific article published on 27 March 2003

Effects of the vasopeptidase inhibitor omapatrilat on peri- and postmyocardial infarction in Zucker lean rats.

artículo científico publicado en 2005

Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.

artículo científico publicado en 2015

Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial

artículo científico publicado en 2016

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial

artículo científico publicado en 2016

Elevated mean arterial pressure in the ovariectomized rat was normalized by ET(A) receptor antagonist therapy: absence of cardiac hypertrophy and fibrosis

artículo científico publicado en 2002

Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis

scientific article published on 01 December 2018

Estimating the Long-Term Treatment Benefits of Sacubitril–Valsartan

article

Evolving towards a more realistic approach to the importance of left ventricular ejection fraction and sex in heart failure and its therapy

scientific article published on 30 March 2020

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

artículo científico publicado en 2002

Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected].

artículo científico publicado en 2014

Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial

artículo científico

Forearm reactive hyperemic blood flow and arm-cranking exercise capacity in healthy and heart failure subjects

artículo científico publicado en 2002

Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review

artículo científico

Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trials

artículo científico publicado en 2015

Genotype-dependent increase in plasma ACE activity after CABG is prevented by ACE inhibition.

artículo científico publicado en 2003

Geographic variations in the PARADIGM-HF heart failure trial.

artículo científico publicado en 2016

Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial

artículo científico publicado en 2018

Health-Related Quality of Life Outcomes in PARADIGM-HF.

artículo científico publicado en 2017

Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

scientific article published on 10 July 2019

Heart Failure with Mid-range Ejection Fraction - What is it, if Anything?

scientific article published on 01 December 2020

Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry

artículo científico publicado en 2005

Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes

artículo científico

Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas

scientific article published on 10 December 2018

High-dose prednisone in patients with heart failure and hyperuricemia: friend and foe?

artículo científico publicado en 2013

High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

artículo científico publicado en 2008

Identification of serum soluble ST2 receptor as a novel heart failure biomarker

artículo científico publicado en 2003

Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Pr

artículo científico publicado en 2016

Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.

artículo científico publicado en 2017

Impact of Malnutrition Using Geriatric Nutritional Risk Index in Heart Failure With Preserved Ejection Fraction

artículo científico publicado en 2019

Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial

artículo científico publicado en 2005

Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).

artículo científico publicado en 2014

Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial

artículo científico publicado en 2005

Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction

scientific article published on 01 November 2004

Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study

artículo científico publicado en 2008

Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow-up from the STICH trial

artículo científico publicado en 2015

Impacts of right ventricular function and venous congestion on renal response during depletion in acute heart failure

scientific article published on 13 May 2020

Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction

artículo científico publicado en 2014

Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).

artículo científico

Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH.

artículo científico publicado en 2015

Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial

artículo científico publicado en 2005

Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression

artículo científico publicado en 2002

Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiot

artículo científico publicado en 2018

Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis

scientific article published on 06 February 2019

Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction

artículo científico publicado en 2006

Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support

artículo científico publicado en 2006

Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction

article

Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in

artículo científico publicado en 2018

Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure

scientific article published on 01 December 2019

Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure

artículo científico publicado en 2015

Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Fai

artículo científico

Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization

artículo científico publicado en 2016

Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease

artículo científico publicado en 2007

Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy.

artículo científico publicado en 2012

Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease

artículo científico publicado en 2013

Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fraction

artículo científico publicado en 2017

Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study

artículo científico publicado en 2004

Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction

artículo científico publicado en 2006

Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial

artículo científico publicado en 2015

Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction

artículo científico publicado en 2012

Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial).

artículo científico publicado en 2005

Investments in patient-oriented research and population health research are complementary: response to editorial by Gilles Paradis

scientific article published on 01 November 2011

Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure?

artículo científico publicado en 2019

Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale

artículo científico publicado en 2002

L'indépendance de la rédaction du JAMC : des signes positifs.

artículo científico publicado en 2006

Lack of long-term benefits of a 6-month heart failure disease management program

artículo científico publicado en 2007

Left Ventricular Remodeling and Ventricular Arrhythmias After Myocardial Infarction ⬇️

artículo científico publicado el 5 de mayo de 2003

Left ventricular assessment in myocardial infarction: the VALIANT registry

artículo científico publicado en 2005

Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarction

scientific article published on 01 July 2007

Left ventricular hypertrophy and the risk of subsequent left ventricular remodeling following myocardial infarction

artículo científico publicado en 2003

Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren

article

Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years

artículo científico publicado en 2017

Long-term effects of carvedilol on left ventricular function, remodeling, and expression of cardiac cytokines after large myocardial infarction in the rat.

artículo científico publicado en 2002

Long-term outcome in men and women after CABG; results from the IMAGINE trial

artículo científico publicado en 2015

Losartan and acute myocardial infarction in insulin-resistant Zucker fatty rats: reduced ventricular arrhythmias and improved survival

artículo científico publicado en 2005

Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial

artículo científico publicado en 2013

Lymphocytopenia During Hospitalization for Acute Heart Failure and its Relationship with Portal Congestion and Right Ventricular Function

artículo científico publicado en 2020

Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction: A TOPCAT Biorepository Study

artículo científico publicado en 2020

Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure

artículo científico publicado en 2003

Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial

artículo científico publicado en 2012

Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy

scientific article published on 01 August 2019

NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy

artículo científico publicado en 2004

Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure.

artículo científico publicado en 2018

Navigating the crossroads of coronary artery disease and heart failure.

artículo científico publicado en 2006

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure

artículo científico publicado en 2002

New and emerging drugs and device therapies for chronic heart failure in patients with systolic ventricular dysfunction

artículo científico publicado en 2011

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

artículo científico publicado en 2004

Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality

artículo científico publicado en 2016

Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease

artículo científico publicado en 2011

Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF

scientific article published on 08 May 2019

Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both

artículo científico publicado en 2010

Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure

scientific article published on 23 July 2020

Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocc

article

Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model

artículo científico publicado en 2003

Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction

article

Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria

artículo científico publicado en 2004

Predictors of heart failure in patients with stable coronary artery disease: a PEACE study

artículo científico publicado en 2009

Predictors of late development of heart failure in stable survivors of myocardial infarction ⬇️

artículo científico publicado el 15 de octubre de 2003

Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study

artículo científico publicado en 2008

Prevalence and incidence of intraventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: Insights from PARADIGM-HF and ATMOSPHERE

artículo científico publicado en 2020

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

artículo científico publicado en 2006

Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction

artículo científico publicado en 2006

Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure

artículo científico publicado en 2016

Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF

artículo científico publicado en 2019

Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study

artículo científico publicado en 2017

Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure

scientific article published on 29 January 2020

Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction

scientific article published on 01 November 2018

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation

artículo científico publicado en 2017

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

artículo científico publicado en 2004

Prognostic use of echocardiography 1 year after a myocardial infarction

scientific article published on 01 October 2005

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial

artículo científico publicado en 2007

Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease

artículo científico publicado en 2013

Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure)

artículo científico publicado en 2014

Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial.

artículo científico publicado en 2018

Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial

artículo científico publicado en 2022

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

artículo científico publicado en 2008

Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial

artículo científico publicado en 2016

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial

scientific article published on 11 February 2019

Reflecting on governance for CMAJ.

artículo científico publicado en 2006

Regional variability in β-blocker efficacy and safety: a question of "location, location, location"?

scientific article published on 13 May 2014

Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

artículo científico publicado en 2014

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

artículo científico publicado en 2004

Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan

artículo científico publicado en 2002

Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIA

artículo científico publicado en 2008

Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF

artículo científico publicado en 2020

Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction

artículo científico publicado en 2019

Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.

artículo científico publicado en 2018

Renal function and coronary bypass surgery in patients with ischemic heart failure

scientific article published on 03 April 2020

Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

artículo científico publicado en 2006

Response to Letter Regarding Article, “Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both”

Response to The J-Point Revisited

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial

artículo científico publicado en 2008

Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design

artículo científico publicado en 2009

Rhythm control versus rate control for atrial fibrillation and heart failure

artículo científico publicado en 2008

Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction

scientific article published on 01 May 2002

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial

artículo científico publicado en 2016

Risk of All-Cause Mortality, Recurrent Myocardial Infarction, and Heart Failure Hospitalization Associated With Smoking Status Following Myocardial Infarction With Left Ventricular Dysfunction ⬇️

artículo científico publicado el 11 de agosto de 2010

Role of endothelins in congestive heart failure

artículo científico publicado en 2003

Réfléchir sur la gouvernance du JAMC.

artículo científico publicado en 2006

STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment

artículo científico publicado en 2010

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

artículo científico publicado en 2019

Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis

scientific article published on 04 September 2020

Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF.

artículo científico publicado en 2017

Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery

artículo científico publicado en 2004

Serum Uric Acid, Influence of Sacubitril/Valsartan, and Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction: PARAGON-HF

artículo científico publicado en 2020

Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization.

artículo científico publicado en 2015

Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

article

Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical Revascularization

scientific article published on 01 November 2018

Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation

artículo científico publicado en 2017

Spironolactone dose in Heart Failure with Preserved Ejection Fraction: findings from TOPCAT

artículo científico publicado en 2020

Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA-HF trial

scientific article published on 01 April 2020

Subacute and chronic effects of quinapril on cardiac cytokine expression, remodeling, and function after myocardial infarction in the rat.

artículo científico publicado en 2002

Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure).

artículo científico

Sudden Death in Heart Failure with Preserved Ejection Fraction: A Competing Risks Analysis from the TOPCAT Trial.

artículo científico publicado en 2018

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

article

Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function

artículo científico publicado en 2008

Sustained postoperative anaemia is associated with an impaired outcome after coronary artery bypass graft surgery: insights from the IMAGINE trial

artículo científico publicado en 2011

Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial.

artículo científico publicado en 2017

Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.

artículo científico publicado en 2017

Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failur

artículo científico

The Institute of Circulatory and Respiratory Health Strategic Plan for 2013-2016 Executive Summary

artículo científico publicado en 2014

The Institute of Circulatory and Respiratory Health strategic plan for 2013-2016 executive summary

artículo científico publicado en 2014

The Leadership and Organizational Context Required to Support Patient Partnerships

scientific article published on 01 December 2018

The OPTIMAAL study, not so optimal: the lessons of LIFE, RENAAL and IDNT.

artículo científico publicado en 2003

The STICH trial: evidence‐based conclusions ⬇️

artículo científico publicado el 1 de octubre de 2010

The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial

artículo científico publicado en 2018

The continuous heart failure spectrum: moving beyond an ejection fraction classification

scientific article published on 01 July 2019

The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.

artículo científico publicado en 2006

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

artículo científico publicado en 2006

The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.

artículo científico publicado en 2017

The endothelin system and its role in acute myocardial infarction.

artículo científico publicado en 2003

The epidemic of heart failure: a lucid approach to stemming the rising tide.

artículo científico publicado en 2014

The heart failure challenge: optimizing medical and surgical management

artículo científico publicado en 2006

The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome

artículo científico publicado en 2014

The phenotype and potential origin of nestin+ cardiac myocyte-like cells following infarction

artículo científico publicado en 2009

The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE

scientific article published on 30 April 2020

The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes

artículo científico publicado en 2018

The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial

artículo científico publicado en 2007

Treatment of congestive heart failure: present and future

artículo científico publicado en 2005

Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000.

artículo científico publicado en 2004

Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction

artículo científico publicado en 2017

Ultrafiltration in decompensated heart failure with cardiorenal syndrome

artículo científico publicado en 2012

Understanding energy consumption in high-performance social housing buildings: A case study from Canada

article

Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both

artículo científico publicado en 2005

Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction

scientific article published on 21 June 2019

VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context

artículo científico publicado en 2003

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

artículo científico publicado en 2003

Value of Cardiovascular Magnetic Resonance Imaging-Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Fail

artículo científico publicado en 2017

Value of the electrocardiogram in predicting left ventricular enlargement and dysfunction after myocardial infarction

artículo científico publicado en 2003

Vasopeptidase inhibition peri- and post-MI in Zucker insulin resistant rats: effect on MI size, arrhythmias, remodeling, function and fetal gene expression

artículo científico publicado en 2005

Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I

artículo científico publicado en 2003

Vasopeptidase inhibitors: a new class of dual zinc metallopeptidase inhibitors for cardiorenal therapeutics

artículo científico publicado en 2002

Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction

artículo científico publicado en 2002

Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme

artículo científico publicado en 2016

β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda